ロード中...
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients
Interferon-β (IFN-β) is a current effective treatment for multiple sclerosis (MS) and exerts its therapeutic effects by down-modulating the systemic immune response and cytokine signaling. In clinical practice there are several formulations of interferon including a low dose of IFN-β 1a formulation...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3395433/ https://ncbi.nlm.nih.gov/pubmed/21658727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2011.05.024 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|